Henry Schein, Inc. (NASDAQ:HSIC) was upgraded by Piper Jaffray Companies from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Friday, Marketbeat reports.

Other equities analysts have also issued research reports about the company. Jefferies Group LLC reiterated a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research note on Friday, July 21st. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective for the company in a research note on Monday, August 7th. Finally, Credit Suisse Group reiterated a “hold” rating and set a $80.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $93.30.

Henry Schein (NASDAQ:HSIC) traded down 1.42% during mid-day trading on Friday, reaching $81.70. The company’s stock had a trading volume of 993,237 shares. The company has a market capitalization of $6.46 billion, a price-to-earnings ratio of 11.94 and a beta of 1.10. The stock has a 50-day moving average price of $170.49 and a 200-day moving average price of $175.55. Henry Schein has a one year low of $73.11 and a one year high of $93.50.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $0.82 EPS. Equities research analysts forecast that Henry Schein will post $7.27 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Henry Schein, Inc. (HSIC) Upgraded to “Overweight” by Piper Jaffray Companies” was first posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/09/15/henry-schein-inc-hsic-upgraded-to-overweight-by-piper-jaffray-companies.html.

In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.27% of the stock is owned by insiders.

A number of hedge funds have recently bought and sold shares of the stock. Gs Investments Inc. acquired a new stake in Henry Schein in the 2nd quarter worth about $884,000. Toronto Dominion Bank boosted its holdings in Henry Schein by 25.7% in the 2nd quarter. Toronto Dominion Bank now owns 26,872 shares of the company’s stock worth $4,917,000 after buying an additional 5,487 shares during the last quarter. WINTON GROUP Ltd boosted its holdings in Henry Schein by 14.9% in the 2nd quarter. WINTON GROUP Ltd now owns 11,297 shares of the company’s stock worth $2,068,000 after buying an additional 1,465 shares during the last quarter. Colony Group LLC boosted its holdings in Henry Schein by 1.3% in the 2nd quarter. Colony Group LLC now owns 12,734 shares of the company’s stock worth $2,331,000 after buying an additional 158 shares during the last quarter. Finally, Verition Fund Management LLC boosted its holdings in Henry Schein by 130.7% in the 2nd quarter. Verition Fund Management LLC now owns 4,152 shares of the company’s stock worth $760,000 after buying an additional 2,352 shares during the last quarter. Institutional investors own 89.05% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.